Who
Robert C. Gay
Director
Company insider
Files Form 4 as: Director, Angel Studios; Director, Merrimack Pharmaceuticals.
In numbers
- Trades disclosed
- 17
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 3 Apr 2012
- Last trade
- 23 Jul 2026
- Last filed
- 24 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jul 2026filed 24 Jul 2026 | ANGX Angel StudiosStreaming & media | SEC FORM 4 Code M | —2,648 | filing |
| 23 Jul 2026filed 24 Jul 2026 | ANGX Angel Studiosoption or derivative · Streaming & media | SEC FORM 4 Code M | —2,648 | filing |
| 23 Jul 2026filed 24 Jul 2026 | ANGX Angel Studiosoption or derivative · Streaming & media | SEC FORM 4 Code M | —2,648 | filing |
| 23 Jul 2026filed 24 Jul 2026 | ANGX Angel StudiosStreaming & media | SEC FORM 4 Code M | —2,648 | filing |
| 22 May 2026filed 26 May 2026 | ANGX Angel StudiosStreaming & media | SEC FORM 4 Code M | —5,296 | filing |
| 22 May 2026filed 26 May 2026 | ANGX Angel Studiosoption or derivative · Streaming & media | SEC FORM 4 Code M | —5,296 | filing |
| 22 May 2026filed 26 May 2026 | ANGX Angel Studiosoption or derivative · Streaming & media | SEC FORM 4 Code M | —5,296 | filing |
| 22 May 2026filed 26 May 2026 | ANGX Angel StudiosStreaming & media | SEC FORM 4 Code M | —5,296 | filing |
| 23 Oct 2025filed 28 Oct 2025 | ANGX Angel Studiosoption or derivative · Streaming & media | SEC FORM 4 Code A | —10,593 | filing |
| 3 Apr 2012filed 5 Apr 2012 | Merrimack Pharmaceuticalsoption or derivative | SEC FORM 4 Code C | —113,586 at $0.00 | filing |
| 3 Apr 2012filed 5 Apr 2012 | Merrimack Pharmaceuticalsoption or derivative | SEC FORM 4 Code C | —142,857 at $0.00 | filing |
| 3 Apr 2012filed 5 Apr 2012 | Merrimack Pharmaceuticalsoption or derivative | SEC FORM 4 Code C | —113,586 at $0.00 | filing |
| 3 Apr 2012filed 5 Apr 2012 | Merrimack Pharmaceuticalsoption or derivative | SEC FORM 4 Code C | —142,857 at $0.00 | filing |
| 3 Apr 2012filed 5 Apr 2012 | Merrimack Pharmaceuticals | SEC FORM 4 Code C | —175,316 | filing |
| 3 Apr 2012filed 5 Apr 2012 | Merrimack Pharmaceuticals | SEC FORM 4 Code C | —142,857 | filing |
| 3 Apr 2012filed 5 Apr 2012 | Merrimack Pharmaceuticals | SEC FORM 4 Code C | —175,316 | filing |
| 3 Apr 2012filed 5 Apr 2012 | Merrimack Pharmaceuticals | SEC FORM 4 Code C | —142,857 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.